NovogeneAIT Genomics

NovogeneAIT Genomics is rated 3 out of 5 in the category biotechnology. Read and write reviews about NovogeneAIT Genomics. NovogeneAIT Genomics Singapore Pte Ltd is joint venture between Novogene and AITBiotech. We provide both research and clinical Next Generation Sequencing (NGS) services in Singapore, ASEAN and other Asia Pacific region. Based out of Genome Institute of Singapore (GIS), NovogeneAIT currently operates the largest NGS capacity in South East Asia, with multiple units of illumina Novaseq, HiSeq to support public research projects and empower large scale sequencing initiatives. We offer reliable and cost effective NGS services and bioinformatics data analysis for a wide range of applications including Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), De Novo sequencing, Bisulfite Sequencing, RNA seq, Amplicon Sequencing, Metagenomics etc. NovogeneAIT also collaborates with researchers to develop clinical next generation sequencing applications including inherited disease panels, targeted oncology panels for stratified cancer treatment and cardiogenomics.